Morphologic features of response to Gleevec (Imatinib) treatment of GIST

被引：3
|
作者：
Colecchia, M [1 ]
Diment, J [1 ]
机构：
[1] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY | 2003年 / 11卷 / 02期
关键词：
D O I：
10.1177/106689690301100209
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [21] Reintroduction of imatinib in GIST
    Reid T.
    Journal of Gastrointestinal Cancer, 2013, 44 (4) : 385 - 392
  • [22] FDA Updates Gleevec Label for GIST Patients
    Schmidt, Charlie
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (05): : 346 - 346
  • [23] Imatinib Mesylate (Gleevec) induced hepatitis
    Rudraraju, M
    Chaudary, N
    Fazili, D
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S258 - S258
  • [24] Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT
    Valls Ferrusola, Eulalia
    Garcia Garzon, Juan Ramon
    Ponce Lopez, Ana
    Soler Peter, Marina
    Fuertes Cabero, Silvia
    Moragas Solanes, Merce
    Riera Gil, Eduard
    Carrio Gasset, Ignasi
    Lomena Caballero, Francisco
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2012, 104 (07) : 360 - 366
  • [25] Emergence of Secondary Resistance to Imatinib in Recurrent Gastric GIST Response
    Dudeja, Vikas
    Gupta, Panjak
    Al-Refaie, Waddah B.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (12) : 2020 - 2020
  • [26] FDG PET in the evaluation of Gleevec treatment in patients with gastrointestinal stroma cell tumors (GIST).
    Jager, PL
    Gietema, JA
    van der Graaf, WT
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 24P - 24P
  • [27] Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST
    Gasparotto, Daniela
    Miolo, Gianmaria
    Torrisi, Elena
    Canzonieri, Vincenzo
    Bertola, Giulio
    Libra, Massimo
    Marzotto, Alessandra
    Maestro, Roberta
    Buonadonna, Angela
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (05) : 639 - 640
  • [28] Response to Imatinib Rechallenge of GIST That Recurs Following Completion of Adjuvant Imatinib Treatment - the First Analysis in the SSGXVIII/AIO Trial Patient Population
    Reichardt, P.
    Hartmann, J. T.
    Hall, K. Sundby
    Eriksson, M.
    Schuette, J.
    Ramadori, G.
    Hohenberger, P.
    Duyster, J.
    Leinonen, M.
    Joensuu, H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : 15 - 15
  • [29] Long-term efficacy of imatinib for treatment of metastatic GIST
    Shreyaskumar Patel
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 277 - 286
  • [30] Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST
    Daniela Gasparotto
    Gianmaria Miolo
    Elena Torrisi
    Vincenzo Canzonieri
    Giulio Bertola
    Massimo Libra
    Alessandra Marzotto
    Roberta Maestro
    Angela Buonadonna
    International Journal of Colorectal Disease, 2014, 29 : 639 - 640
12345